ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

ConditionCoronary Artery Disease

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorEmory University

About this trial

The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.

Eligibility criteria

Qualifiers

All adult patients (≥ 18 years of age) undergoing PCI for de novo CAD using DCB

Disqualifiers

Patients under the age of 18; PCI procedures without the utilization of DCB; PCI procedures for non de novo lesions

Trial design

Treatments tested in this trial

Not listed

Trial groups

5,000 Participants

are grouped into 1 trial group

Locations

Germany

Universitatsklinikum des Saarlandes Homberg (Efze) Germany

Serbia

University Clinical Centre of Serbia Belgrade Serbia

United States

Arizona

Banner University Medical Center85006, Phoenix United States

Florida

Holy Cross Health Fort Lauderdale33308, Fort Lauderdale United States

Sponsors and collaborators

Emory University

Lead sponsor

Source ClinicalTrials.gov